131 related articles for article (PubMed ID: 30501509)
1. Pharmacokinetics and acetylcholine releasing effects of ginsenoside Rg1 in hippocampus of beta-amyloid model rats.
Liu Y; Gao Y; Li KX; Xue W
J Asian Nat Prod Res; 2019 Aug; 21(8):772-781. PubMed ID: 30501509
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of ginsenoside Rg1 in rat medial prefrontal cortex, hippocampus, and lateral ventricle after subcutaneous administration.
Xue W; Liu Y; Qi WY; Gao Y; Li M; Shi AX; Li KX
J Asian Nat Prod Res; 2016 Jun; 18(6):587-95. PubMed ID: 27324597
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 reduces β‑amyloid levels by inhibiting CDΚ5‑induced PPARγ phosphorylation in a neuron model of Alzheimer's disease.
Quan Q; Li X; Feng J; Hou J; Li M; Zhang B
Mol Med Rep; 2020 Oct; 22(4):3277-3288. PubMed ID: 32945455
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.
Shi J; Xue W; Zhao WJ; Li KX
Acta Pharmacol Sin; 2013 Feb; 34(2):214-20. PubMed ID: 23202798
[TBL] [Abstract][Full Text] [Related]
5. Plasma and intracerebral pharmacokinetics and pharmacodynamics modeling for the acetylcholine releasing effect of ginsenoside Rg1 in mPFC of A
Xue W; Gao Y; Xie PP; Liu Y; Qi WY; Shi AX; Li KX
J Asian Nat Prod Res; 2021 Mar; 23(3):294-306. PubMed ID: 33771049
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 ameliorates hippocampal long-term potentiation and memory in an Alzheimer's disease model.
Li F; Wu X; Li J; Niu Q
Mol Med Rep; 2016 Jun; 13(6):4904-10. PubMed ID: 27082952
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.
Quan Q; Wang J; Li X; Wang Y
PLoS One; 2013; 8(3):e59155. PubMed ID: 23520555
[TBL] [Abstract][Full Text] [Related]
8. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease].
Li X; Liu Y; Zhang X; Yuan H; Quan Q
Zhongguo Zhong Yao Za Zhi; 2010 Dec; 35(24):3339-43. PubMed ID: 21438403
[TBL] [Abstract][Full Text] [Related]
10. Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.
Zhang X; Wang J; Xing Y; Gong L; Li H; Wu Z; Li Y; Wang J; Wang Y; Dong L; Li S
Neuroscience; 2012 Sep; 220():191-200. PubMed ID: 22728092
[TBL] [Abstract][Full Text] [Related]
11. Ginsenosides attenuate d-galactose- and AlCl
Zhang Y; Pi Z; Song F; Liu Z
J Ethnopharmacol; 2016 Dec; 194():188-195. PubMed ID: 27612432
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats.
Song XY; Hu JF; Chu SF; Zhang Z; Xu S; Yuan YH; Han N; Liu Y; Niu F; He X; Chen NH
Eur J Pharmacol; 2013 Jun; 710(1-3):29-38. PubMed ID: 23588117
[TBL] [Abstract][Full Text] [Related]
13. Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease.
Nie L; Xia J; Li H; Zhang Z; Yang Y; Huang X; He Z; Liu J; Yang X
Oxid Med Cell Longev; 2017; 2017():6473506. PubMed ID: 29204248
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ginsenoside Rg1 on behaviors and hippocampal amino acids in depressive-like rats].
Wu HF; Zhu CH; Guo JY
Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3117-21. PubMed ID: 23311165
[TBL] [Abstract][Full Text] [Related]
15. A UFLC-MS/MS method with a switching ionization mode for simultaneous quantitation of polygalaxanthone III, four ginsenosides and tumulosic acid in rat plasma: application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats.
Lv C; Li Q; Zhang Y; Sui Z; He B; Xu H; Yin Y; Chen X; Bi K
J Mass Spectrom; 2013 Aug; 48(8):904-13. PubMed ID: 23893636
[TBL] [Abstract][Full Text] [Related]
16. A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Zhan S; Guo W; Shao Q; Fan X; Li Z; Cheng Y
J Ethnopharmacol; 2014 Mar; 152(2):333-9. PubMed ID: 24462784
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPARγ/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury.
Yang Y; Li X; Zhang L; Liu L; Jing G; Cai H
Int J Clin Exp Pathol; 2015; 8(3):2484-94. PubMed ID: 26045754
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA/CREB activity, and improves cognitive performance in SAMP8 mice.
Shi YQ; Huang TW; Chen LM; Pan XD; Zhang J; Zhu YG; Chen XC
J Alzheimers Dis; 2010; 19(3):977-89. PubMed ID: 20157253
[TBL] [Abstract][Full Text] [Related]
19. [Research of anti-aging mechanism of ginsenoside Rg1 on brain].
Li CP; Zhang MS; Liu J; Geng S; Li J; Zhu JH; Zhang YY; Jia YY; Wang L; Wang SH; Wang YP
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4442-7. PubMed ID: 25850282
[TBL] [Abstract][Full Text] [Related]
20. [Study on PK-PD characteristics of ginsenoside Rg1 and Rb1, in rats with myocardial ischemia following intravenous administration of shengmai injection].
Zhan SY; Shao Q; Li Z; Wang Y; Fan XH
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(7):1300-5. PubMed ID: 25011272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
